Preliminary results from fight-102: a phase 1 study of pemigatinib in Japanese patients with advanced malignancies

被引：1

作者：

Kuboki, Yasutoshi ^{[1
]}

Furukawa, Masayuki ^{[2
]}

Takahashi, Yasuo ^{[3
]}

Mizuno, Nobumasa ^{[4
]}

Hara, Hiroki ^{[5
]}

Ueno, Makoto ^{[6
]}

Ioka, Tatsuya ^{[7
]}

Takahashi, Shunji ^{[8
]}

Shimizu, Toshio ^{[9
]}

Lihou, Christine F. ^{[10
]}

Tian, Chenwei ^{[10
]}

Ji, Tao ^{[10
]}

Fujiwara, Yutaka ^{[9
]}

机构：

[1] Natl Canc Cent Hosp East, Kashiwa, Chiba, Japan

[2] Kyushu Canc Ctr, Minami Ku, Fukuoka, Fukuoka, Japan

[3] Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan

[4] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan

[5] Saitama Canc Ctr, Saitama, Japan

[6] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan

[7] Osaka Int Canc Inst, Osaka, Japan

[8] JFCR, Canc Inst Hosp, Koto Ku, Tokyo, Japan

[9] Natl Canc Ctr, Chuo Ku, Tokyo, Japan

[10] Incyte Corp, Wilmington, DE USA

来源：

关键词：

D O I：

10.1093/annonc/mdz343.034

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1 - 156

引用

页数：1